School of Dentistry, University Center Univates, Lajeado, RS, Brazil.
School of Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
J Oral Pathol Med. 2018 May;47(5):460-467. doi: 10.1111/jop.12643. Epub 2017 Oct 6.
Oral Squamous Cell Carcinoma (OSCC) presents a tumor microenvironment rich in inflammatory cells. Depending on the stimulus, macrophages can polarize in M1 or M2 profile, where M1 acts as proinflammatory and antitumor, and M2 is anti-inflammatory and shows protumor activity. Several studies have shown that macrophages are important to the prognosis of patients with different types of cancer. Our aim was to conduct a systematic review to evaluate the role of macrophages in the prognosis of OSCC patients. A search in the Pubmed, Scopus, and ISI Web of Knowledge database was performed, and it was included only studies that evaluated the importance of macrophages in the prognosis of OSCC patients. From initial 286 articles, 14 fully attended the inclusion criteria. In the majority of the articles, it was evaluated only CD68, a panmacrophage marker, or CD163, a M2 marker. Only one article evaluated the M1 marker, CD11c. Besides, 5 articles analyzed the presence of macrophages in different areas of the tumor. Higher concentrations of CD68 and CD163 were associated with worse survival. In conclusion, macrophages are important to OSCC patients' prognosis; however, it is necessary to address in which tumor region the presence of polarized macrophage is more important to the outcome.
口腔鳞状细胞癌(OSCC)具有富含炎症细胞的肿瘤微环境。根据刺激的不同,巨噬细胞可以极化为 M1 或 M2 表型,其中 M1 表现为促炎和抗肿瘤,而 M2 则具有抗炎作用并表现出促肿瘤活性。多项研究表明,巨噬细胞对不同类型癌症患者的预后很重要。我们的目的是进行系统评价,以评估巨噬细胞在 OSCC 患者预后中的作用。在 Pubmed、Scopus 和 ISI Web of Knowledge 数据库中进行了检索,仅纳入评估巨噬细胞在 OSCC 患者预后中重要性的研究。从最初的 286 篇文章中,有 14 篇完全符合纳入标准。在大多数文章中,仅评估了 CD68(一种巨噬细胞通用标志物)或 CD163(M2 标志物)。只有一篇文章评估了 M1 标志物 CD11c。此外,有 5 篇文章分析了肿瘤不同区域巨噬细胞的存在。CD68 和 CD163 的浓度较高与生存率较差相关。总之,巨噬细胞对 OSCC 患者的预后很重要;但是,有必要确定极化巨噬细胞在肿瘤的哪个区域对预后更为重要。